Asia Pacific Digestive Enzyme Supplements Market Size, Share & Industry Trends Analysis Report By Application (Additional supplements, Medical & Infant Nutrition and Sports Nutrition), By Origin (Animal, Plant, Microbial), By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Digestive Enzyme Supplements Market is expected to witness market growth of 8.6% CAGR during the forecast period (2022-2028).

Digestion enzyme production can be insufficient at times. These circumstances may result in several issues, such as a disorder known as achlorhydria occurs when the stomach is unable to create hydrochloric acid, which is one of the elements of gastric acid. The body is protected against infections taken with food or water by hydrochloric acid, which also aids in the digestion of food.   People with pancreatic diseases frequently receive prescriptions for digestive enzymes from their doctors.

Pancreatic cancer, pancreatitis, and cystic fibrosis are some of these conditions. Digestion aids are available over-the-counter for people who have problems consuming and digesting dairy products. These are known as supplements for lactase. Lactase is an enzyme that helps human body in digesting lactose. The primary sugar in dairy products is lactose. In those who have difficulty digesting lactose, lactase tablets can help prevent indigestion.

The requirement for digestive enzymes is significantly high in the region due to the robust presence of amoebiasis in regional countries like India. According to the National Health Portal of India. Entamoeba histolytica can be referred as a parasite that is the origin of the disease amoebiasis. Only 10 to 20% of those who acquire E. histolytica become ill as a result of the ailment. Anyone can contract it, but those who live in tropical places with inadequate sanitation tend to get it more frequently.

The China market dominated the Asia Pacific Digestive Enzyme Supplements Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $117.5 Million by 2028.The Japan market is estimated to grow a CAGR of 8% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 9.3% during (2022 - 2028).

Based on Application, the market is segmented into Additional supplements, Medical & Infant Nutrition and Sports Nutrition. Based on Origin, the market is segmented into Animal, Plant, Microbial and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ProThera, Inc., Enzymes, Inc., AST Enzymes, Vemo 99 Ltd., Zeus Biotech Pvt. Ltd., Metagenics, Inc., Xymogen, HVL, LLC, Ortho Molecular Products, Inc., and Enzymedica, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Additional supplements
• Medical & Infant Nutrition
• Sports Nutrition

By Origin

• Animal
• Plant
• Microbial
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• ProThera, Inc.
• Enzymes, Inc.
• AST Enzymes
• Vemo 99 Ltd.
• Zeus Biotech Pvt. Ltd.
• Metagenics, Inc.
• Xymogen
• HVL, LLC
• Ortho Molecular Products, Inc.
• Enzymedica, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free